The role of aberrant hypothalamic opiatergic function in generating polycystic ovaries in the rat.
Treatment of adult female rats with estradiol valerate produces an intractable hypothalamic impairment that ultimately results in anovulatory acyclicity and polycystic ovaries. Evidence from our laboratory suggests that the hypothalamic impairment compromises regulation of the endogenous opioid system engendering a persistent opiatergic suppression of gonadotropin-releasing hormone secretion, which is subsequently reflected in a chronically low pituitary content of gonadotropin-releasing hormone receptors. If such is the case, inhibition of opiatergic transmission should improve the gonadotropin-releasing hormone pattern resulting in an improvement in the pituitary content of gonadotropin-releasing hormone receptors, and in an amelioration of the polycystic condition. We, therefore, treated rats with the polycystic ovarian condition, with daily injections of naltrexone. Within 1 week, there was a significant increase in the pituitary content of gonadotropin-releasing hormone receptors and a marked improvement in ovarian morphology, indicating that the hypothalamic opiatergic system is chronically active, and contributes significantly to the polycystic ovarian condition.
Carriere
P D
PD
Department of Physiology, McGill University, Montréal, Qué., Canada
Farookhi
R
R
Brawer
J R
JR
D000818:Animals; D004723:Endorphins / Q000037:antagonists & inhibitors; D004971:Estrus; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D007031:Hypothalamus / Q000502:physiology*; D007986:Luteinizing Hormone / Q000097:blood; D009271:Naltrexone / Q000494:pharmacology; D010053:Ovary / Q000473:pathology; D010903:Pituitary Gland, Anterior / Q000648:ultrastructure; D011085:Polycystic Ovary Syndrome / Q000209:etiology*; D011388:Prolactin / Q000097:blood; D051381:Rats; D011919:Rats, Inbred Strains; D011966:Receptors, LHRH / Q000502:physiology; D015854:Up-Regulation / Q000502:physiology
D004723:Endorphins; D011966:Receptors, LHRH; D009271:Naltrexone; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone